Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Qi Zhang, Yue-Xiang Ma, Zheng Dai, Bin Zhang, Shan-Shou Liu, Wen-Xiu Li, Chuan-Qing Fu, Qian-Mei Wang & Wen Yin. (2023) Tracking Research on Hemoglobin-Based Oxygen Carriers: A Scientometric Analysis and In-Depth Review. Drug Design, Development and Therapy 17, pages 2549-2571.
Read now
Read now
Thomas Ming Swi Chang. (2022) The role of artificial cells in the fight against COVID-19: deliver vaccine, hemoperfusion removes toxic cytokines, nanobiotherapeutics lower free radicals and pCO2 and replenish blood supply. Artificial Cells, Nanomedicine, and Biotechnology 50:1, pages 240-251.
Read now
Read now
Thomas Ming Swi Chang. (2019) ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 997-1013.
Read now
Read now
Gang Chen & T. M. S. Chang. (2018) Dual effects include antioxidant and pro-oxidation of ascorbic acid on the redox properties of bovine hemoglobin. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 983-992.
Read now
Read now
Chen Guo & Thomas Ming Swi Chang. (2018) Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion. Artificial Cells, Nanomedicine, and Biotechnology 46:7, pages 1349-1363.
Read now
Read now
Articles from other publishers (2)
Thomas Ming Swi Chang. 2022. Blood Substitutes and Oxygen Biotherapeutics. Blood Substitutes and Oxygen Biotherapeutics
199
206
.
Thomas Ming Swi Chang. 2022. Blood Substitutes and Oxygen Biotherapeutics. Blood Substitutes and Oxygen Biotherapeutics
99
115
.